CRYSTALLINE FORMS AND COMPOSITIONS OF CFTR MODULATORS

Crystalline Forms of Compound (I): (Formula (I)) and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed. L'invention concerne des formes...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DHAMANKAR, VARSHA, CHEN, WEICHAO GEORGE, MCCARTY, KATIE, MOSKOWITZ, SAMUEL, GOPINATHAN, NISHANTH, HASELTINE, ERIC L, METZLER, CATHERINE, DOKOU, ELENI, ZHANG, BEILI, FERRIS, LORI ANN, WALTZ, DAVID, DINEHART, KIRK RAYMOND, ROBERTSON, SARAH
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Crystalline Forms of Compound (I): (Formula (I)) and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed. L'invention concerne des formes cristallines du composé (I) : (formule (I)) et des sels pharmaceutiquement acceptables de celles-ci. L'invention concerne également des compositions pharmaceutiques les comprenant, des méthodes de traitement de la fibrose kystique à l'aide de celles-ci, et des procédés de fabrication de celles-ci.